Latest Breaking News On - Graft function - Page 1 : comparemela.com

Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress - Unicycive Therapeutics (NASDAQ:UNCY)

Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress - Unicycive Therapeutics (NASDAQ:UNCY)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSatya medicherlaShalabh guptaEuropean renal associationShire international licensingUnicycive therapeutics incReason researchExchange commissionCompany or unicyciveMoral administrationDrug administrationRenal associatesPreclinical modelHyperphosphatemia demonstrateRelative potency

Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress

LOS ALTOS, Calif., March 25, 2024 (GLOBE NEWSWIRE) Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that multiple presentations will be delivered on the Company’s product candidates, oxylanthanum carbonate (OLC) and UNI-494, at the 61st European Renal Association (ERA) Congress taking place May 23-26, 2024, in Stockholm, Sweden. Shalabh Gupta, MD, Chief Execu

United statesUnited kingdomSatya medicherlaShalabh guptaExchange commissionEuropean renal associationDrug administrationUnicycive therapeutics incCompany or unicyciveReason researchShire international licensingRenal associatesMoral administrationChief executive officerUrinary phosphorous reductionComparative study

CytoSorbents and Aferetica Announce the Commercial Launch in Italy of the PerSorb™ Adsorber and PerLife™ Organ Perfusion System, respectively, at the European Society of Organ Transplantation Congress

CytoSorbents and Aferetica Announce the Commercial Launch in Italy of the PerSorb™ Adsorber and PerLife™ Organ Perfusion System, respectively, at the European Society of Organ Transplantation Congress
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

United statesEmilia romagnaAferetica perlifeChristian steinerEric kimStefano rimondiCytosorbent persorbMaterial commandAferetica press officeM boffinim rinaldi university of turinG remuzzi mario negri instituteF dazzi king collegeCompany codesEuropean unionUs armyL de carlis university of milan bicocca

CytoSorbents and Aferetica Announce the Commercial Launch in Italy of the PerSorb™ Adsorber and PerLife™ Organ Perfusion System, respectively, at the European Society of Organ Transplantation Congress

CytoSorbents and Aferetica Announce the Commercial Launch in Italy of the PerSorb™ Adsorber and PerLife™ Organ Perfusion System, respectively, at the European Society of Organ Transplantation Congress
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesEmilia romagnaChristian steinerEric kimStefano rimondiCytosorbent persorbMaterial commandM boffinim rinaldi university of turinG remuzzi mario negri instituteF dazzi king collegeEuropean unionUs armyL de carlis university of milan bicoccaBlood instituteCytosorbents corporationNational heart